The United States Department of Defense has announced a new policy requiring all active-duty service members aged 30 and older to undergo annual screening for testosterone deficiency. Defense Secretary Pete Hegseth introduced the initiative, framing it as a measure to ensure troops maintain optimal physical and mental readiness. The screenings will be integrated into the existing periodic health assessments that service members already complete each year. While the testing is mandatory for those 30 and older, service members under 30 may request the screening on a voluntary basis.
According to the Department of Defense, the program is intended to address potential health markers that can impact long-term performance and physical resilience. Secretary Hegseth emphasized that the initiative is not designed for artificial performance enhancement, but rather to restore and optimize natural biological capabilities. He stated that the rigors of the modern battlefield demand high levels of psychological and mental readiness, and that identifying and addressing deficiencies early could help sustain the force.
If a service member is found to have a deficiency and treatment is recommended, participation in testosterone replacement therapy remains entirely voluntary. The policy does not mandate any specific medical intervention, leaving the final decision to the individual service member in consultation with their healthcare providers. The Pentagon has not yet provided specific details regarding how the program will be applied to female service members or if there will be any implications for those who choose to decline recommended treatments.
This move follows broader discussions within the administration regarding hormone health and accessibility to replacement therapies. As the military begins to roll out these screenings, officials are expected to monitor the health data collected to better understand the prevalence of hormone-related issues within the ranks. The practical impact of this policy will depend on how medical providers interpret the results and how service members choose to engage with the optional treatment pathways offered by the Department of Defense.